Datwyler in the media

The Swiss online platform maschinenmarkt.ch reports on Datwyler joining the Science Based Targets initiative (SBTi).

Datwyler commits to science-based emission reduction targets by joining the Science Based Targets initiative (SBTi).

Dirk Lambrecht talks about the status of the integration of the two newly acquired companies QSR and Xinhui and comments on the potential ban on aluminum coffee capsules being discussed by the EU.

Geert Moens, Global Platform Leader Vial Closure Systems, Datwyler Healthcare, discusses recent technologies in the film and spray coatings market.

In this technical article, Datwyler expert Jakub Kadlcak explains how thermal management of battery electric vehicles can be improved by the intelligent use of the right materials and composites.

Tom Lenaerts, Head of Global Process Engineering for Datwyler, speaks about smart manufacturing benefits in the pharma supply chain.

Datwyler is further enhancing its global capabilities in O-ring development and production with the transfer of its state-of-the-art cold runner injection molding technology to Asia and North America.

Datwyler Healthcare’s Tabassam Sharif, regulatory affairs manager, and Eugene Polini, technical key account manager, explain how parenteral packaging suppliers are optimising their technologies and processes to meet regulatory requirements.

China has one of the fastest growing pharmaceutical markets in the world, which means a rising need for high-end packaging components naturally follows. To serve the demand and complete its global footprint, leading parenteral packaging component provider Datwyler recently announced its acquisition of Yantai Xinhui Packing, which includes a state-of-the-art production plant in Yantai, China.

A deeper look at the trend towards electrification and the possibilities surrounding haptic feedback. Haptic feedback is an example of these advances and is an area that is increasingly important in terms of vehicle design, both in terms of aesthetics and functionality.

Carina van Eester, Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges discusses key developments in pharmaceutical cartridges, including the next generation in aluminum seals and the wearable injectors of the future.

Alliance to Zero President Sebastian Gerner, Vice-President Robert O’Beirn and Committee Member Sabrina Gérard talk with ONdrugDelivery about the Alliance, an association for pharma and biotech supply chain companies that aims to facilitate the transition of the pharma sector to compliance with net-zero emissions.

Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, shares key learnings since the launch of Datwyler’s NeoFlex™ plungers at the start of the COVID-19 pandemic.

The apprentice camp of the Datwyler plants in Uri has a long tradition and took place for the 29th time this summer. For five days, the first-year apprentices performed community service in Golzern near Bristen.

Drug delivery devices are seeing rapid adoption in the injectable drug market due to the convenience and ease of administration for patients. Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges, Carina Van Eester, discusses Datwyler’s cartridge offerings designed with delivery device requirements in mind in the latest Special Injection Report with Drug Development & Delivery.

Datwyler shows how Electro Active Polymers (EAP) can be used for various customized haptic feedback technology solutions in today’s car interior designs.

The Uri-based company wants to develop new materials needed for hybrid and electric vehicles.

The Uri-based components manufacturer Datwyler is committed to promoting women. The importance of equal pay is just as self-evident to us as the ongoing development of our diversity strategy. Six women in different functions and positions are evidence of this.

Datwyler is able to make an important contribution to the global fight against the pandemic with its system-critical elastomer components. The company is supporting the leading pharmaceutical companies in the provision of COVID-19 vaccines.

Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, shares key learnings since the launch of Datwyler’s NeoFlex™ plungers at the start of the COVID-19 pandemic.

Datwyler’s Global Head of Marketing and Product Management, Massimo Mainetti, discusses how packaging suppliers are helping to reach global herd immunity in 3 years.

Focus on system-critical elastomer components for attractive global markets generates added value.

A pair of Switzerland-based companies—Datwyler and CTSystems—have developed a new electroactive polymer (EAP) actuator technology. The partners aim to commercialize this in the next three to four years for use in pumps and valves, as well as haptic feedback devices.

In Korean publication, Plastic Net, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.

In Korean Packaging Association, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.

In May, Project Jumpstart, a public-private initiative, was announced that will pump $138 million into the production of 100 million prefilled syringes by the end of this year and another 500 million in 2021, should a COVID-19 vaccine become available. Yet, industry gurus do not necessarily agree that the pandemic will have a positive impact on the injection delivery market. Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the important role that coated plungers play in ensuring the appropriate functionality and compatibility of injection devices.

When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.

«When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.